Intelligent design
of living systems

Platform

Asimov builds tools to program living cells.
Our mammalian cell engineering platform advances the design and manufacture of biologics and gene therapies.

1

CAD software

Computer-aided design, simulation, and debugging of genetic systems.
2

Cell lines

GMP host cell lines for improved biologics and viral vector manufacturing.
3

Genetic parts

Optimized vectors and genetic parts database for custom functionality.
We’re currently partnering with leading biopharma companies and CDMOs.
Contact us to learn more.

Focus Areas

Synthetic biology is ushering in an era where therapeutics can be iteratively engineered rather than discovered. Our platform enables an engineering mindset for next-generation medicines.

Monoclonal antibody
manufacturing

Multifunctional and
difficult-to-express
molecule manufacturing

T

Design of vector payloads
and capsid-specific
optimization

AAV and lentiviral
manufacturing

Technology

Full-stack bioengineering.

1

Synthetic Biology

Nature has evolved billions of useful molecular devices in the form of genes, across the tree of life. We source, catalog, refine, and remix these genetic components to build new biological systems.

2

Computer-Aided Design

Biology is complex, and genetic engineering unlocks an unbounded design space. Computational modeling is critical to move synthetic biology beyond traditional brute force screening.

3

Multi-omics Measurement

Genome-scale, multi-omics measurement technologies provide deep views into the cell. These techniques permit pathway analysis at the scale of a whole cell, and inspection down at single-nucleotide resolution.

4

Machine Learning

Machine learning bridges large-scale datasets with mechanistic models of biology. Artificial intelligence can augment human capabilities to design and understand biological complexity.

Asimov Inside

We endeavor to build the genetic programs powering the world's most impactful biotechnologies. One day, entire genomes will be designed from the ground up. Come help us build this future.

Meet Our Team

Ours is a culture of recombination, where diverse expertise and experiences intermix. Our team spans synthetic biology, machine learning, computational biology, and automation.

Liza Antonelli

Research Technician

Rachel Bozadjian

Research Associate

Michelle Chang

Synthetic Biologist II

Haewon Chung

Synthetic Biologist II

Amber Delhagen

Senior Research Associate

Douglas Densmore

Co-Founder

Nick Emery

Automation Engineer II

Alina Ferdman

Senior Software Engineer

Jamie Freeman

Director of Business Development and Commercial Strategy

Xiaoran Fu

Head of DNA

Jeremy Gam

Senior Synthetic Biologist

Zach Gottlieb

Senior Software Engineer

Vincent Huang

Software Intern

Brianna Jayanthi

Synthetic Biologist

Maya Kaul

Research Associate

Rachel Kelemen

Synthetic Biologist

Michael Leonard

Associate Synthetic Biologist

Kevin LeShane

Head of Software Design

Alec Nielsen

Co-Founder & CEO

Dan Phelps

Senior Software Engineer

Jessica Rock

Laboratory Operations Manager

Felicity Rudge

Senior Business Development Manager

Dylan Samperi

Automation Engineer

Raja Srinivas

Co-Founder

Christopher Stach

Synthetic Biologist II

Mark Stockdale

Strategic Alliance Director

Susanne Talbot

Talent Acquisition Specialist

Georgian Tutuianu

Software Intern

David Tulga

Senior Automation Engineer

Drew Ward

Senior Director of Strategic Business Development

Dinghai Zheng

Senior Computational Biologist

Christopher Voigt

Co-Founder

Jorge Conde

Board Member

Investors

We are backed by exceptional investors at the intersection of biology, computation, and engineering.

Andreessen HorowitzAME Cloud VenturesData CollectiveHorizons VenturesPillarWing

Grow With Us

If you share our drive to design living systems, we’re interested in hearing from you.

Join us

News

Press Release

Asimov Selected by DARPA to Develop AI Design Engine for Synthetic Biology

Read More

Press Release

Asimov Appoints James J. Collins to Scientific Advisory Board

Read More

Press Release

MIT Startup Exchange Names Asimov to STEX25

Read More

News

Silicon Valley Sees a Future in Circuits Made of DNA

Read More

Blog

The Circuitry In Our Cells

Read More

Press Release

Genetic Circuits Startup Asimov Raises Seed Round Led by Andreessen Horowitz

Read More
“Synthetic biology — a field that includes methods of modifying the genes of living organisms to change what the organisms do — will play an increasingly important role in manufacturing various products.”
- Xconomy
“Because biology is everywhere, living cells have applications in everything from food and materials to agriculture to healthcare.”
- Andreessen Horowitz
“MIT biological engineers have created a programming language that allows them to rapidly design complex, DNA-encoded circuits that give new functions to living cells.”
- MIT News

Address

1325 Boylston Street,
Suite 500
Boston, MA 02215

Contact